KemPharm Logo
KemPharm to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference
September 23, 2021 07:30 ET | KemPharm
CELEBRATION, Fla., Sept. 23, 2021 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ: KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, today...
KemPharm Logo
KemPharm to Present at the Virtual H.C. Wainwright 23rd Annual Global Investment Conference
September 09, 2021 07:30 ET | KemPharm
CELEBRATION, Fla., Sept. 09, 2021 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ: KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, today...
KemPharm Logo
KemPharm Appoints Tamara A. Seymour to Board of Directors
August 18, 2021 16:45 ET | KemPharm
CELEBRATION, Fla., Aug. 18, 2021 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ: KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, announced...
KemPharm Logo
KemPharm Reports Second Quarter 2021 Financial Results
August 12, 2021 16:05 ET | KemPharm
Corporate and Regulatory Highlights U.S. Commercial Launch of AZSTARYS™ Initiated on July 21, 2021Serdexmethylphenidate (SDX) Classified as a Schedule IV Controlled Substance by the DEAAnnounced...
KemPharm Logo
KemPharm to Report Second Quarter 2021 Results
August 05, 2021 07:30 ET | KemPharm
Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Thursday, August 12, 2021, 4:30 p.m. ET CELEBRATION, Fla., Aug. 05, 2021 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ:...
KemPharm Logo
KemPharm Announces U.S. Launch of Innovative ADHD Treatment AZSTARYS™ (serdexmethylphenidate and dexmethylphenidate capsules) by Corium, Inc.
July 21, 2021 08:30 ET | KemPharm
CELEBRATION, Fla., July 21, 2021 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ: KMPH), a specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs, today...
KemPharm Logo
KemPharm Announces Exercise of Existing Warrants and Issuance of Warrants in Private Placement
June 18, 2021 09:15 ET | KemPharm
CELEBRATION, Fla., June 18, 2021 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ: KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, today...
KemPharm Logo
KemPharm Issues Letter to Shareholders
June 16, 2021 07:30 ET | KemPharm
CELEBRATION, Fla., June 16, 2021 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ: KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, today...
KemPharm Logo
KemPharm to be Added to Russell 2000® and Russell 3000® Indexes Effective June 28, 2021
June 09, 2021 07:30 ET | KemPharm
CELEBRATION, Fla., June 09, 2021 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ: KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, announced...
KemPharm Logo
KemPharm Executives to Participate in Panel Discussions During Upcoming June 2021 Conferences
June 03, 2021 07:30 ET | KemPharm
CELEBRATION, Fla., June 03, 2021 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ: KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, today...